UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The risk of secondary malignancies over 30 years after the treatment of non‐Hodgkin lymphoma

Cancer, 2006-07, Vol.107 (1), p.108-115

2006

Volltextzugriff (PDF)

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

Neuro-oncology (Charlottesville, Va.), 2018-04, Vol.20 (5), p.666-673

2018

Volltextzugriff (PDF)

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)

Neuro-oncology (Charlottesville, Va.), 2021-07, Vol.23 (7), p.1125-1138

2021

Volltextzugriff (PDF)

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (7), p.966-974

2018

Volltextzugriff (PDF)

RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

International journal of radiation oncology, biology, physics, 2013-08, Vol.86 (5), p.880-884

2013

Volltextzugriff (PDF)

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes

Neurosurgery, 2019-01, Vol.84 (1), p.66-76

2019

Volltextzugriff (PDF)

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy

Neuro-oncology practice, 2019-07, Vol.6 (4), p.274-282

2019

Volltextzugriff (PDF)

Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825

Neuro-oncology advances, 2022-01, Vol.4 (1), p.vdac152

2022

Volltextzugriff (PDF)

Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development

Journal of neuro-oncology, 2007-05, Vol.83 (1), p.33-38

2007

Volltextzugriff (PDF)

NCOG-20. BRAIN ATROPHY IN GLIOBLASTOMA PATIENTS FOLLOWING TREATMENT WITH CHEMORADIATION OR CHEMORADIATION WITH ANTI-ANGIOGENIC THERAPY IN NRG/RTOG 0825 PARTICIPANTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Suppl 7), p.vii201-vii201

2022

Volltextzugriff (PDF)

Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial

Journal of clinical oncology, 2014-12, Vol.32 (34), p.3810-3816

2014

Volltextzugriff (PDF)

Time interval to the development of breast carcinoma after treatment for Hodgkin disease

Cancer, 2004-09, Vol.101 (6), p.1275-1282

2004

Volltextzugriff (PDF)

Novalis intensity-modulated radiosurgery: methods for pretreatment planning

Neurosurgery, 2008-05, Vol.62 (5 Suppl), p.A2-A10

2008

Volltextzugriff (PDF)

The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease

American journal of clinical oncology, 2006-04, Vol.29 (2), p.189-195

2006

Volltextzugriff (PDF)

The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant

American journal of clinical oncology, 2007-04, Vol.30 (2), p.156-162

2007

Volltextzugriff (PDF)

Extraneural metastatic medulloblastoma in an adult

Journal of neuro-oncology, 2006-06, Vol.78 (2), p.191-196

2006

Volltextzugriff (PDF)

NCOG-20. BRAIN ATROPHY IN GLIOBLASTOMA PATIENTS FOLLOWING TREATMENT WITH CHEMORADIATION OR CHEMORADIATION WITH ANTI-ANGIOGENIC THERAPY IN NRG/RTOG 0825 PARTICIPANTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii201-vii201

2022

Volltextzugriff (PDF)

NRG/RTOG 1122: phase II double-blinded, placebo-controlled study of bevacizumab with/without trebananib in patients with recurrent glioblastoma or gliosarcoma

Cancer, 2020-03, Vol.126 (12), p.2821-2828

2020

Volltextzugriff (PDF)

CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933

Journal of neuro-oncology, 2016-01, Vol.126 (2), p.327-336

2016

Volltextzugriff (PDF)

Basic principles of radiobiology, radiotherapy, and radiosurgery

Neurosurgery clinics of North America, 2004-10, Vol.15 (4), p.467-479

2004

Volltextzugriff (PDF)

Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer

Seminars in surgical oncology, 2003-09, Vol.21 (2), p.111-121

2003

Volltextzugriff (PDF)

Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2049-2049

2016

Volltextzugriff (PDF)

NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi159-vi160

2017

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(18)
Female
(15)
Oncology
(15)
Clinical Neurology
(13)
Male
(13)
Neurosciences & Neurology
(13)
Middle Aged
(12)
Adult
(11)
Aged
(9)
Treatment Outcome
(6)
Tumors
(6)
Biological And Medical Sciences
(5)
Brain Cancer
(5)
Glioblastoma
(5)
Medical Sciences
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Brain Neoplasms - Therapy
(4)
Clinical Investigations
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The risk of secondary malignancies over 30 years after the treatment of non‐Hodgkin lymphoma

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

NRG/RTOG 1122: A phase 2, double‐blinded, placebo‐controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database

RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy

Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825

Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development

NCOG-20. BRAIN ATROPHY IN GLIOBLASTOMA PATIENTS FOLLOWING TREATMENT WITH CHEMORADIATION OR CHEMORADIATION WITH ANTI-ANGIOGENIC THERAPY IN NRG/RTOG 0825 PARTICIPANTS

Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial

Time interval to the development of breast carcinoma after treatment for Hodgkin disease

Novalis intensity-modulated radiosurgery: methods for pretreatment planning

The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease

The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant

Extraneural metastatic medulloblastoma in an adult

NCOG-20. BRAIN ATROPHY IN GLIOBLASTOMA PATIENTS FOLLOWING TREATMENT WITH CHEMORADIATION OR CHEMORADIATION WITH ANTI-ANGIOGENIC THERAPY IN NRG/RTOG 0825 PARTICIPANTS

NRG/RTOG 1122: phase II double-blinded, placebo-controlled study of bevacizumab with/without trebananib in patients with recurrent glioblastoma or gliosarcoma

CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933

Basic principles of radiobiology, radiotherapy, and radiosurgery

Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer

Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825

NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825

Suchergebnisse filtern